Clinical trial
Using Circulating Tumor Cells to Diagnose and Predict Prognosis in Metastatic Nasopharyngeal Carcinoma Patients
NCT02505139 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Using Circulating Tumor Cells to Diagnose and Predict Prognosis in Metastatic Nasopharyngeal Carcinoma Patients
- Lead sponsor
- Sun Yat-sen University
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2014
- Completion date
- August 31, 2016
- Enrollment
- 166 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.